Skip to main content
. 2019 Jul 1;20(13):3238. doi: 10.3390/ijms20133238

Figure 2.

Figure 2

Cell cycle change after EANT treatment. (A,B) Cell cycle distribution patterns and statistics. Without or with NAC pretreatment, breast cancer cells (MCF7 and SKBR3) were treated with 0 (control with DMSO only), 5, 15, and 25 μg/mL of EANT for 24 h, i.e., EANT vs. NAC/EANT. For each cycle phase, treatments labeled without the same lower-case letters indicate significant difference. p < 0.05~0.0001. Data, mean ± SD (n = 3). Positive controls for subG1 accumulation and G2/M arrest were provided in the Supplementary Figure S2A,B.